K&K Herbal Poland S.A. primarily focuses on the distribution and sale of dietary supplements and cosmetics, medical devices, and veterinary products in Poland.
Excellent balance sheet and fair value.
Share Price & News
How has K&K Herbal Poland's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: KKH's share price has been volatile over the past 3 months.
7 Day Return
PL Retail Distributors
1 Year Return
PL Retail Distributors
Return vs Industry: KKH exceeded the Polish Retail Distributors industry which returned 11.4% over the past year.
Return vs Market: KKH exceeded the Polish Market which returned -7.7% over the past year.
Price Volatility Vs. Market
How volatile is K&K Herbal Poland's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StInvestors Who Bought K&K Herbal Poland (WSE:KKH) Shares Five Years Ago Are Now Down 42%
2 months ago | Simply Wall StWhat Kind Of Investor Owns Most Of K&K Herbal Poland S.A. (WSE:KKH)?
3 months ago | Simply Wall StThe K&K Herbal Poland (WSE:KKH) Share Price Has Gained 43% And Shareholders Are Hoping For More
Is K&K Herbal Poland undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: KKH (PLN0.19) is trading below our estimate of fair value (PLN0.93)
Significantly Below Fair Value: KKH is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: KKH is unprofitable, so we can't compare its PE Ratio to the Retail Distributors industry average.
PE vs Market: KKH is unprofitable, so we can't compare its PE Ratio to the Polish market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate KKH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: KKH is good value based on its PB Ratio (1.1x) compared to the PL Retail Distributors industry average (1.2x).
How is K&K Herbal Poland forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Retail industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as K&K Herbal Poland has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine whether K&K Herbal Poland is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- K&K Herbal Poland competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Retail industry.
How has K&K Herbal Poland performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: KKH is currently unprofitable.
Growing Profit Margin: KKH is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: KKH is unprofitable, and losses have increased over the past 5 years at a rate of -67% per year.
Accelerating Growth: Unable to compare KKH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: KKH is unprofitable, making it difficult to compare its past year earnings growth to the Retail Distributors industry (-1.9%).
Return on Equity
High ROE: KKH has a negative Return on Equity (-14.81%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
How is K&K Herbal Poland's financial position?
Financial Position Analysis
Short Term Liabilities: KKH's short term assets (PLN1.2M) exceed its short term liabilities (PLN141.2K).
Long Term Liabilities: KKH's short term assets (PLN1.2M) exceed its long term liabilities (PLN84.9K).
Debt to Equity History and Analysis
Debt Level: KKH's debt to equity ratio (0.1%) is considered satisfactory.
Reducing Debt: KKH had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Inventory Level: KKH has a high level of physical assets or inventory.
Debt Coverage by Assets: KKH's debt is covered by short term assets (assets are 650.9x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: KKH has been profitable on average in the past, therefore cash runway is not a concern.
Forecast Cash Runway: KKH has been profitable on average in the past, therefore cash runway is not a concern.
What is K&K Herbal Poland's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate KKH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate KKH's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if KKH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if KKH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of KKH's dividend in 3 years as they are not forecast to pay a notable one for the Polish market.
How experienced are the management team and are they aligned to shareholders interests?
Krzysztof Milaszewski 0
Mr. Krzysztof Milaszewski serves as Chairman of The Management Board at K&K Herbal Poland Spólka Akcyjna.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
K&K Herbal Poland S.A.'s company bio, employee growth, exchange listings and data sources
- Name: K&K Herbal Poland S.A.
- Ticker: KKH
- Exchange: WSE
- Industry: Distributors
- Sector: Retail
- Market Cap: zł1.407m
- Shares outstanding: 7.41m
- Website: https://kkpoland.pl
- K&K Herbal Poland S.A.
- ul. Limanowskiego 1A lok. 8
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|KKH||WSE (Warsaw Stock Exchange)||Yes||Common Bearer Shares||PL||PLN||Jul 2012|
K&K Herbal Poland S.A. primarily focuses on the distribution and sale of dietary supplements and cosmetics, medical devices, and veterinary products in Poland. The company provides EnteFace, a face mask cleaner; Enterosgel, a medical device; and contactless thermometer, such as SYNERGICA SG1000. It offers its medical devices under the SYNERGICA brand. The company sells its products through pharmaceutical wholesalers, pharmacies, medical and herbal shops, and other partners, as well as through online stores. K&K Herbal Poland S.A. is based in Wieliczka, Poland.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/16 21:48|
|End of Day Share Price||2020/02/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.